| Brachytherapy . | CTV D90 (Gy) . | CTV V100 (%) . | Rectum D2cc (Gy) . | Small bowel D2cc (Gy) . |
|---|---|---|---|---|
| # 1 | 7.8 | 99.68 | 2.7 | 1.9 |
| # 2 | 8.0 | 99.83 | 1.4 | 1.9 |
| # 3 | 7.6 | 98.57 | 1.6 | 1.5 |
| # 4 | 8.3 | 99.48 | 2.5 | 1.5 |
| Brachytherapy . | CTV D90 (Gy) . | CTV V100 (%) . | Rectum D2cc (Gy) . | Small bowel D2cc (Gy) . |
|---|---|---|---|---|
| # 1 | 7.8 | 99.68 | 2.7 | 1.9 |
| # 2 | 8.0 | 99.83 | 1.4 | 1.9 |
| # 3 | 7.6 | 98.57 | 1.6 | 1.5 |
| # 4 | 8.3 | 99.48 | 2.5 | 1.5 |
CTV, clinical target volume; D90, minimal dose delivered to 90% of target volume; V100, fractional volume of the organ receiving 100% of the prescribed dose; Rectum D2cc and Small bowel D2cc, doses for most exposed 2 cc volumes of rectum and small bowel, respectively;
| Brachytherapy . | CTV D90 (Gy) . | CTV V100 (%) . | Rectum D2cc (Gy) . | Small bowel D2cc (Gy) . |
|---|---|---|---|---|
| # 1 | 7.8 | 99.68 | 2.7 | 1.9 |
| # 2 | 8.0 | 99.83 | 1.4 | 1.9 |
| # 3 | 7.6 | 98.57 | 1.6 | 1.5 |
| # 4 | 8.3 | 99.48 | 2.5 | 1.5 |
| Brachytherapy . | CTV D90 (Gy) . | CTV V100 (%) . | Rectum D2cc (Gy) . | Small bowel D2cc (Gy) . |
|---|---|---|---|---|
| # 1 | 7.8 | 99.68 | 2.7 | 1.9 |
| # 2 | 8.0 | 99.83 | 1.4 | 1.9 |
| # 3 | 7.6 | 98.57 | 1.6 | 1.5 |
| # 4 | 8.3 | 99.48 | 2.5 | 1.5 |
CTV, clinical target volume; D90, minimal dose delivered to 90% of target volume; V100, fractional volume of the organ receiving 100% of the prescribed dose; Rectum D2cc and Small bowel D2cc, doses for most exposed 2 cc volumes of rectum and small bowel, respectively;
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
